Ocular Hypertension

Ophthalmologists must consider the cost-effectiveness of available treatment options for glaucoma and the impact this may have on patients, according to a speaker at the American Glaucoma Society meeting.

Excimer laser trabeculostomy reduced both IOP and medication burden in patients with open-angle glaucoma or ocular hypertension, according to a poster at the American Glaucoma Society meeting.

Patients with primary open-angle glaucoma or ocular hypertension who received QLS-111 experienced lower IOP in two phase 2 trials, according to a press release from Qlaris Bio.

KOLOA, Hawaii — Intracranial pressure may be just as critical of a factor in the progression of glaucoma as IOP, according to a speaker here at Hawaiian Eye 2025.

Stand-alone canaloplasty and trabeculotomy with the Omni surgical system showed positive real-world outcomes in reducing IOP and medication use, according to a study published in American Journal of Ophthalmology.

The top glaucoma articles on Healio in 2024 included an overview of a more holistic approach to managing the disease as well as safety and efficacy data for a sustained-release bimatoprost drug delivery platform.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Constance O. Okeke, MD, MSCE, discusses a study that investigated the impact of latanoprostene bunod on IOP in patients with open-angle glaucoma and ocular hypertension.

Timolol microdrops administered with the Nanodropper Adaptor were as effective as conventional drops at lowering IOP among patients with open-angle glaucoma and ocular hypertension, according to a study published in Ophthalmology.

SpyGlass Pharma has completed enrollment in its phase 1/2 clinical trial evaluating a long-term drug delivery platform of bimatoprost for glaucoma and ocular hypertension, according to a press release.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Patrick Mooney, CEO of Spyglass Pharma, discusses the company’s IOL-based bimatoprost drug delivery platform for patients with open-angle glaucoma or ocular hypertension.